Has Qnexa been approved by the FDA?
Note: The U.S. Food and Drug Administration late Tuesday approved Qnexa, a diet pill made by Vivus and renamed Qsymia, despite evidence that it poses significant risks but has little evidence of long-lasting weight loss.
Is Qnexa safe?
In the FDA’s analysis of Qnexa safety, there were some ominous comments: There was indeed evidence of increased heart rate and acidic body fluids in people taking Qnexa. The FDA states that “only a long-term” study can tell whether Qnexa increases the risk of heart disease in obese people already at high heart risk.
What is the generic brand for Qsymia?
Some or all forms of Qsymia may become available as generic phentermine/topiramate after June 2029, depending on FDA approval and patent expiration. It is possible that Qsymia may become available as generic phentermine/topiramate after June 2029. Generics are typically much cheaper than the branded version of a drug.
How much weight do you lose on Qsymia?
Qsymia was broadly effective—about 62 percent of patients on the lower dose and 69 percent on the higher dose lost more than 5 percent of their body weight.
Is qnexa a prescription drug?
That would make Qnexa the only prescription appetite suppressant approved for long-term use available in the U.S. The only other widely marketed prescription weight loss drug, orlistat — sold by prescription as Xenical and over-the-counter as Alli — works by blocking dietary fat absorption.
Does qnexa raise blood pressure?
WASHINGTON (Reuters) – An experimental weight loss drug that pairs a stimulant with an epilepsy drug helped patients lose weight and keep it off for a year and also lowered blood pressure, a researcher said on Tuesday.
Is Qnexa the best appetite suppressant?
FDA Reconsiders Weight Loss Drug Qnexa. That would make Qnexa the only prescription appetite suppressant approved for long-term use available in the U.S. The only other widely marketed prescription weight loss drug, orlistat — sold by prescription as Xenical and over-the-counter as Alli — works by blocking dietary fat absorption.
How effective is Qnexa for weight loss?
The average weight loss for patients on the higher dose of Qnexa was 14.4% of body weight, compared to 6.7% among patients on the lower dose and 2.1% among patients taking a placebo. 48% of those in the higher-dose group lost 15% or more of their body weight, compared to 12% in the lower-dose group and 6% in the placebo group.
What is the new weight loss pill Qsymia?
Sept. 18, 2012 — The prescription weight loss pill Qsymia is now for sale from certified pharmacies. Qsymia — pronounced kyoo-SIM-ee-uh, according to Vivus Pharmaceuticals — is the first new weight loss drug to reach market in 13 years. Vivus chose the name Qsymia after the FDA rejected a previous name, Qnexa.
Will Qnexa be approved by the FDA?
California-based pharmaceutical company Vivus Inc, is now asking for limited approval for its oral combination drug Qnexa, which would exclude women in their childbearing years. According to the company, the FDA is scheduled to make an approval decision next April. If approved, the drug could be commercially available soon after that.